is hims still selling compounded semaglutide The FDA announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company & Hers to yank its new (Wegovy) weight-loss pill from the Hims cancels plans to sell

Schmitt C, Portron A, Jadidi S, Sarkar N, DiMarchi R

As future amino acid-based treatments seem to depend on identifying potent ligands to promote endogenous GLP-1 secretion in humans, and as the effects of oral amino acid supplementation on GLP-1 secretion in humans have been variable [44, 47,48,49], the effect of the individual amino acids on GLP-1 secretion in humans warrants further clarification

Some small human studies suggest that yerba mate or green mate (same active compound) can be helpful for fat loss and appetite reduction

Source: Bertalan Mesk, MD, PhDs Post Should diabetics currently on GLP-1 agonists wear continuous glucose monitoring devices (CGMs)

This pattern reinforced the value of titration before settling into long term dosing